Mimic
Natural health product licensed in Canada
- Licence holder
- Magnum Nutraceuticals Inc.
- NPN or DIN-HM
- 80053529
- Status
- Active licence
- Licence date
- 3 September 2014
- Revision date
- 5 January 2024
- Form
- Capsule, enrobage gélatine
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Chrome Source : Levure enrichie de chrome | 200 mcg | Not calculated |
| 5,6-Dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium Source : Berberine hydrochloride | 90 mg | Not calculated |
| Acide DL-alpha lipoÏque Source : Acide DL-alpha-lipoÏque | 100 mg | Not calculated |
| Cinnamomum verum Source : Écorce (branche) Extraction ratio : 8:1 Dry plant equivalent : 800 mg | 100 mg | Not calculated |
| Gynostemma pentaphyllum Source : Gynostemma pentaphyllum - plante entière Potency : 90 % Gypenosides | 90 mg | Not calculated |
Non-medicinal ingredients
cellulose, Stéarate de magnésium, Gélatine, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Provides antioxidants for the maintenance of good health. Provides support for healthy glucose metabolism. Helps the body to metabolize carbohydrates and fats. Factor in the maintenance of good health. Helps to prevent chromium deficiency.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80053529
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.